DUBLIN, Ireland, March 05, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (MURA) (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies ...
WALTHAM, Mass. and DUBLIN, Ireland, April 24, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (MURA) (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered ...
GREEN BAY, Wis. (WBAY) - Benefits stemming from the NFL Draft continue to trickle through the Green Bay community. Local artist Zane Statz created a 70-foot-long mural for the event that helped raise ...
Nemvaleukin alfa (nemvaleukin) is a novel, engineered cytokine designed to leverage antitumor effects of the IL-2 pathway while mitigating its hallmark toxicities that limit its use. Nemvaleukin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results